CliffBio
biologic

Gammaked, Gamunex-C

Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified

Loss of exclusivityOctober 2037projected — 12-year biologic exclusivity estimate
CompanyGrifols →View the full company profile on CliffBio

Drug detail

Brand nameGammaked, Gamunex-C
Active ingredientImmune Globulin Injection (Human) 10% Caprylate/Chromatography Purified
Strength20G/200ML
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
FDA approvalOctober 2025
Marketing statusRx

More from Grifols

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Gammaked, Gamunex-C patent cliff — loss of exclusivity October 2037 | CliffBio